Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 90,963 shares at $27.56 ($2.4M) on 2016-04-01, disclosed to the SEC on 2016-04-05.
Open-market sale of $2.4M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.69 | 40,506 | $1.0M | 43.4% |
| 2 | $26.67 | 38,080 | $1.0M | 42.4% |
| 3 | $27.56 | 12,377 | $341K | 14.2% |
| Total | $26.35 avg | 90,963 | $2.4M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |